Riskpilot← Back to searchSign inGet full accessObvius Orthopaedics AB
ABActiveOrg 5568166457Allmänningsgatan 4General medical practice activities · NACE 8621Est. 20104 employees
Revenue 2025
SEK 8M
+12% vs 2024
EBITDA margin
21.9%
+4% vs 2024
Equity ratio
65.3%
Financial strength
Net profit 2025
SEK 1,1M
+2% vs 2024
| Revenue | SEK 8M | +12% |
| EBITDA | SEK 1,7M | +4% |
| Net profit | SEK 1,1M | +2% |
| Total assets | SEK 3M | +5% |
| Equity | SEK 2M | +10% |
| Employees | 4 | — |
Legal name
Obvius Orthopaedics AB
Org number
5568166457
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 augusti 2010
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utföra medicinska bedömningar och konsultuppdrag samt intygsförskrivningar jämte därmed förenlig verksamhet.
Address
Allmänningsgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 151 | 2 435 | 5 673 | 7 108 | 7 964 |
| Staff expenses | — | −370 | −2 004 | −2 614 | −2 900 |
| EBITDA | 599 | 1 267 | 1 687 | 1 676 | 1 746 |
| Depreciation & amort. | −106 | −371 | −433 | −309 | −375 |
| EBIT | 493 | 897 | 1 254 | 1 367 | 1 371 |
| Net financials | −11 | −64 | −63 | −27 | −5 |
| Profit before tax | 212 | 569 | 1 192 | 1 339 | 1 366 |
| Tax | −44 | −68 | −249 | −288 | −293 |
| Net profit | 168 | 501 | 942 | 1 051 | 1 072 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 108 | 2 718 | 3 261 | 2 895 | 3 032 |
| Equity | 412 | 913 | 1 455 | 1 806 | 1 978 |
| Long-term debt | 989 | 811 | 636 | 0 | — |
| Short-term debt | 367 | 390 | 567 | 486 | 450 |
| Total debt | 1 356 | 1 202 | 1 202 | 486 | 450 |
EBITDA margin
21.9%
This company
15.8%
Market median
+39% vs market
20212025
Equity ratio
65.3%
This company
38.2%
Market median
+71% vs market
20212025
Return on equity
54.2%
This company
18.4%
Market median
+195% vs market
20212025
Net profit margin
13.5%
This company
8.1%
Market median
+67% vs market
20212025
Asset turnover
2.63×
This company
1.12×
Market median
+135% vs market
20212025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Audit | Audit | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Obvius Orthopaedics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erdinc Aron Cicek | Audit | 0 companies |
| Anna Elisabet Kroon | Deputy Board Member | 0 companies |
| Hans Peter Cratz | Board of Directors | 0 companies |